Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001048445 | SCV001212452 | likely benign | Duchenne muscular dystrophy | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200317 | SCV001371240 | uncertain significance | not provided | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003117723 | SCV003800956 | uncertain significance | not specified | 2023-01-11 | criteria provided, single submitter | clinical testing | Variant summary: DMD c.4604C>T (p.Thr1535Met) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 182799 control chromosomes, including one hemizygote. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4604C>T has been reported in the literature in at-least one individual affected with dilated cardiomyopathy (example: Dal Ferro_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Dystrophinopathies. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV001827305 | SCV002085312 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-10-29 | no assertion criteria provided | clinical testing |